Biolase, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 56,430 57,356 48,858 26,225
Cost of Revenue 34,900 30,878 27,540 17,400
Gross Profit 21,530 26,478 21,318 8,825
Operating Expenses
Research and Development 4,029 4,684 4,311 3,790
Sales, General and Admin. 28,497 24,325 21,011 16,495
Non-Recurring Items - - - 35
Other - - - -
Operating Income (10,996) (2,531) (4,004) (11,495)
Income From Continuing Operations
Add'l Income/Expense Items (50) (175) (88) (107)
Earnings Before Interest and Tax (11,046) (2,706) (4,092) (11,602)
Interest Expense 600 239 305 361
Earnings Before Tax (11,646) (2,945) (4,397) (11,963)
Income Tax (164) 111 89 58
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,482) (3,056) (4,486) (12,021)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,482) (3,056) (4,486) (12,021)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,482) (3,056) (4,486) (12,021)